Anti-leishmanial evaluation of C2-aryl quinolines: Mechanistic insight on bioenergetics and sterol biosynthetic pathway of Leishmania braziliensis-Reference-Cited by-同舟云学术

Anti-leishmanial evaluation of C2-aryl quinolines: Mechanistic insight on bioenergetics and sterol biosynthetic pathway of Leishmania braziliensis

Published:2013-07 Issue:14 Volume:21 Page:4426-4431
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Bompart Daznia,Núñez-Durán Jorge,Rodríguez Daniel,Kouznetsov Vladimir V.,Meléndez Gómez Carlos M.,Sojo Felipe,Arvelo Francisco,Visbal Gonzalo,Alvarez Alvaro,Serrano-Martín Xenón,García-Marchán Yael

Funder

Fondo Nacional de Ciencia Tecnología e Innovación

Patrimonio Autónomo Fondo Nacional de Financiamiento para la Ciencia, la Tecnología y la Innovación, Francisco José de Caldas

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference48 articles.

1. World Health Organization, ‘Control of the Leishmaniases’, World Health Organization Technical Report Series, 2010, 949, 1.

2. Chemotherapy of leishmaniasis part II: synthesis and bioevaluation of substituted arylketene dithioacetals as antileishmanial agents

3. Leishmaniasis chemotherapy—challenges and opportunities

4. Antiprotozoal activities of phospholipid analogues

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigational new drugs for the treatment of leishmaniasis;Expert Opinion on Investigational Drugs;2024-09-10

2. Using Quinolin-4-Ones as Convenient Common Precursors for a Metal-Free Total Synthesis of Both Dubamine and Graveoline Alkaloids and Diverse Structural Analogues;Molecules;2024-04-25

3. Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective;Pharmaceuticals;2024-02-22

4. Advances in Antileishmanial Chemotherapy;Challenges and Solutions Against Visceral Leishmaniasis;2023

5. Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates;Pharmaceutics;2022-07-30